Is intralymphatic immunotherapy ready for clinical use in patients with grass pollen allergy?

Journal of Allergy and Clinical Immunology

Volumn 132, Issue 5, 2013, Pages

  Witten, Marianne ^a   Malling, Hans Jørgen ^a   Blom, Lars ^a   Poulsen, Britta C ^a   Poulsen, Lars K ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRASS POLLEN EXTRACT; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; INTERLEUKIN 10; INTERLEUKIN 4; PLACEBO; TRANSCRIPTION FACTOR FOXP3;

DRUG EFFICACY; DRUG WITHDRAWAL; GRASS POLLEN; HUMAN; IMMUNOTHERAPY; INJECTION SITE DISCOMFORT; INJECTION SITE REACTION; INTRACUTANEOUS TEST; INTRALYMPHATIC IMMUNOTHERAPY; LETTER; NOSE PROVOCATION TEST; PERIPHERAL BLOOD MONONUCLEAR CELL; PRICK TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY OF LIFE; RHINOCONJUNCTIVITIS; VISUAL ANALOG SCALE;

EID: 84887022494     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2013.07.033     Document Type: Article

References (21)

1. E. Alvarez-Cuesta, J. Bousquet, G.W. Canonica, S.R. Durham, H.J. Malling, and E. Valovirta Standards for practical allergen-specific immunotherapy Allergy 61 suppl 82 2006 1 20
2. G. Senti, B.M. Prinz Vavricka, I. Erdmann, M.I. Diaz, R. Markus, and S.J. McCormack Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial Proc Natl Acad Sci U S A 105 2008 17908 17912
3. G. Senti, R. Crameri, D. Kuster, P. Johansen, J.M. Martinez-Gomez, and N. Graf Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections J Allergy Clin Immunol 129 2012 1290 1296
4. T. Hylander, L. Latif, U. Petersson-Westin, and L.O. Cardell Intralymphatic allergen-specific immunotherapy: an effective and safe alternative treatment route for pollen-induced allergic rhinitis J Allergy Clin Immunol 131 2013 412 420
5. V. Godicke, and F. Hundt Registration trials for specific immunotherapy in Europe: advanced guidance from the new European Medical Agency guideline Allergy 65 2010 1499 1505
6. G.W. Canonica, C.E. Baena-Cagnani, J. Bousquet, P.J. Bousquet, R.F. Lockey, and H.J. Malling Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce Allergy 62 2007 317 324
7. N.M. Ivers, I.J. Halperin, J. Barnsley, J.M. Grimshaw, B.R. Shah, and K. Tu Allocation techniques for balance at baseline in cluster randomized trials: a methodological review Trials 13 2012 120
8. M.H. Shamji, C. Ljorring, J.N. Francis, M.A. Calderon, M. Larche, and I. Kimber Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy Allergy 67 2012 217 226
9. E. Alvarez-Cuesta, J. Bousquet, G.W. Canonica, S.R. Durham, H.J. Malling, and E. Valovirta Standards for practical allergen-specific immunotherapy Allergy 61 suppl 82 2006 1 20
10. N.M. Ivers, I.J. Halperin, J. Barnsley, J.M. Grimshaw, B.R. Shah, and K. Tu Allocation techniques for balance at baseline in cluster randomized trials: a methodological review Trials 13 2012 120
11. ICH harmonized tripartite guideline: guideline for good clinical practice J Postgrad Med 47 2001 45 50
12. K.F. Schulz, D.G. Altman, and D. Moher CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials J Pharmacol Pharmacother 1 2010 100 107
13. V. Godicke, and F. Hundt Registration trials for specific immunotherapy in Europe: advanced guidance from the new European Medical Agency guideline Allergy 65 2010 1499 1505
14. G.W. Canonica, C.E. Baena-Cagnani, J. Bousquet, P.J. Bousquet, R.F. Lockey, and H.J. Malling Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce Allergy 62 2007 317 324
15. E.F. Juniper, and G.H. Guyatt Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis Clin Exp Allergy 21 1991 77 83
16. P.S. Skov, and S. Norn A simplified method for measuring basophil histamine release and blocking antibodies in hay fever patients. Basophil histamine content and cell preservation Acta Allergol 32 1977 170 182
17. P.S. Skov, H. Mosbech, S. Norn, and B. Weeke Sensitive glass microfibre-based histamine analysis for allergy testing in washed blood cells. Results compared with conventional leukocyte histamine release assay Allergy 40 1985 213 218
18. C.R. Parish, M.H. Glidden, B.J. Quah, and H.S. Warren Use of the intracellular fluorescent dye CFSE to monitor lymphocyte migration and proliferation Curr Protoc Immunol 2009 Chapter 4:Unit 4
19. L. Blom, and L.K. Poulsen IL-1 family members IL-18 and IL-33 upregulate the inflammatory potential of differentiated human Th1 and Th2 cultures J Immunol 189 2012 4331 4337
20. L. Blom, B.C. Poulsen, B.M. Jensen, A. Hansen, and L.K. Poulsen IL-33 induces IL-9 production in human CD4+ T cells and basophils PLoS One 6 2011 e21695
21. J. Bousquet, H.J. Schunemann, P.J. Bousquet, C. Bachert, G.W. Canonica, and T.B. Casale How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement Allergy 66 2011 765 774